Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a newer version of the page content. This reflects an update to the page text or layout.
    Difference
    0.0%
    Check dated 2026-07-25T14:07:09.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    A newer revision identifier appears on the page, indicating a backend or template update; the study content and user-facing information remain unchanged.
    Difference
    0.0%
    Check dated 2026-07-04T04:54:01.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.6.0 to v3.6.2, indicating a newer version of the ClinicalTrials.gov study page.
    Difference
    0.0%
    Check dated 2026-06-27T02:55:15.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The study page now indicates recruitment is closed and results have been posted. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the 28-day treatment cycle duration is stated.
    Difference
    6%
    Check dated 2026-06-12T16:53:09.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.5.5), replacing the previous v3.5.4, signaling a minor backend or template update without changes to study data.
    Difference
    0.0%
    Check dated 2026-06-05T16:12:09.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    Removed the text '2024-01-26' and the label 'Certification/Extension First Posted' from the Study Record Dates section, updating the historical QC entries shown for this study record. This change updates what is visible in the record’s QC history without altering the study data or eligibility.
    Difference
    0.1%
    Check dated 2026-05-29T14:13:39.000Z thumbnail image

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.